News

Takeda completes sale of Xiidra to Novartis

Takeda intends to use the proceeds from the sale to reduce its debt and accelerate deleveraging toward its target of 2x net debt/adjusted EBITDA in the medium-term following closing of the Shire acquisition.

Jul 02, 2019

By : Team ABLE

Boehringer Ingelheim expands NASH R&D pipeline with new compound from Yuhan Corporation

The collaboration brings together Yuhan Corporation’s expertise in FGF21 biology, obesity and NASH with Boehringer Ingelheim’s pharmaceutical expertise.

Jul 02, 2019

By : Team ABLE

DBT calls for fellowship in genetic diagnostics

DBT has launched a 6-month ‘Fellowship in Genetic Diagnostics’ for Faculty/Clinicians only from Government Medical Colleges and Hospitals.

Jul 02, 2019

By : Team ABLE

DBT invites comments on Biological Data Storage, Access and Sharing Policy of India

DBT has invited comments on ‘Biological Data Storage, Access and Sharing Policy of India’ from all the stakeholders- government agencies, institutions, industry/researchers engaged in Biological Sciences R&D.

Jul 02, 2019

By : Team ABLE

Biotech startup String Bio raises funds from Ankur Capital, other investors

Bengaluru-based biotechnology company String Bio on Thursday announced that it has raised an undisclosed amount in funding from investors including Oil & Natural Gas Corporation Limited (ONGC), France’s Seventure Partners, and Ankur Capital.

Jul 01, 2019

By : Team ABLE